Cubist Systematic Strategies, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$141,337
-98.8%
1,708
-98.9%
0.00%
-98.6%
Q4 2022$11,797,185
+153.4%
149,996
+138.5%
0.07%
+165.4%
Q3 2022$4,656,000
+81.3%
62,894
+59.6%
0.03%
+62.5%
Q2 2022$2,568,000
+199.3%
39,403
+190.3%
0.02%
+128.6%
Q1 2022$858,000
-74.1%
13,571
-78.3%
0.01%
-78.1%
Q4 2021$3,315,000
+144.6%
62,506
+225.6%
0.03%
+88.2%
Q3 2021$1,355,000
-68.4%
19,197
-70.2%
0.02%
-64.6%
Q2 2021$4,286,000
-13.8%
64,321
+43.5%
0.05%
-25.0%
Q1 2021$4,975,000
+690.9%
44,812
+746.5%
0.06%
+611.1%
Q4 2020$629,000
-53.0%
5,294
-65.4%
0.01%
-55.0%
Q3 2020$1,337,000
-91.6%
15,320
-91.4%
0.02%
-92.7%
Q2 2020$15,928,000
+9269.4%
177,846
+10343.1%
0.28%
+5400.0%
Q1 2020$170,000
-94.1%
1,703
-93.2%
0.01%
-90.6%
Q4 2019$2,888,000
+153.3%
25,131
+178.1%
0.05%
+130.4%
Q3 2019$1,140,000
+16185.7%
9,036
+16035.7%
0.02%
Q2 2019$7,000
-99.1%
56
-99.4%
0.00%
-100.0%
Q1 2019$773,000
+544.2%
8,834
+638.6%
0.02%
+316.7%
Q4 2018$120,000
-64.8%
1,196
-59.8%
0.01%
-68.4%
Q3 2018$341,000
-86.7%
2,973
-89.6%
0.02%
-85.3%
Q2 2018$2,564,000
+1316.6%
28,594
+1055.3%
0.13%
+1072.7%
Q1 2018$181,000
-65.2%
2,475
-72.4%
0.01%
-60.7%
Q4 2017$520,000
+33.7%
8,961
+3.3%
0.03%
+27.3%
Q3 2017$389,000
+49.6%
8,677
+31.6%
0.02%
+29.4%
Q2 2017$260,000
-36.6%
6,595
-35.4%
0.02%
-48.5%
Q4 2016$410,000
+130.3%
10,207
+107.4%
0.03%
+200.0%
Q3 2016$178,000
-72.6%
4,922
-78.0%
0.01%
-71.1%
Q2 2016$650,000
+123.4%
22,405
+148.8%
0.04%
+153.3%
Q3 2015$291,000
+3.2%
9,006
+32.0%
0.02%
+7.1%
Q2 2015$282,000
-2.1%
6,822
-11.3%
0.01%
-12.5%
Q4 2014$288,000
+12.9%
7,694
+5.4%
0.02%0.0%
Q3 2014$255,000
-23.9%
7,300
-23.2%
0.02%
-20.0%
Q2 2014$335,0009,5030.02%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders